Literature DB >> 7832751

Effect of retinoic acid on protein synthesis by foetal bovine chondrocytes in high-density culture: down-regulation of the glucose-regulated protein, GRP-78, and type II collagen.

A M Freyria1, M C Ronzière, M M Boutillon, D Herbage.   

Abstract

The effect of 0.1-10 microM retinoic acid (RA) on foetal bovine chondrocytes was investigated in high-density cultures (0.6 x 10(6) cells/cm2). After 5 days of culture in ascorbate-free medium, control chondrocytes presented a typical rounded shape and synthesized type II, IX, XI and III collagens. After RA treatment on days 2-5 of culture, the cells exhibited a fibroblast-like shape and decreased synthesis of total protein (48%) and pepsinresistant proteins (60%) as determined by [35S]methionine labelling. Addition of RA was not followed by the expression of type I collagen, but induced quantitative changes in the synthesis of cartilage-specific collagens (II, IX and XI) as measured by direct autoradiography of the corresponding bands after SDS/PAGE. The main change was in type II collagen synthesis, with a 80% decrease in the cell-layer fraction and a 89% decrease in culture-medium fraction; inhibition of type IX and XI collagen synthesis was limited to 25 and 31% respectively. Modifications to intracellular proteins induced by RA were determined by using two-dimensional electrophoresis associated with a computerized imaging system. Synthesis of one of the more abundant proteins (pI 4.8; 78 kDa) was decreased by 75% after RA treatment. This protein was characterized by micro-sequencing as the glucose-regulated protein 78 (GRP 78). It was reported previously to bind denatured collagen and mutated type I procollagen molecule and to function as a molecular chaperone for collagen molecules. It remains to demonstrate whether the parallel down-regulation of GRP 78 and type II collagen observed here corresponds to a co-ordinate regulation of these two proteins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7832751      PMCID: PMC1136374          DOI: 10.1042/bj3050391

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

1.  An Hsp70-like protein in the ER: identity with the 78 kd glucose-regulated protein and immunoglobulin heavy chain binding protein.

Authors:  S Munro; H R Pelham
Journal:  Cell       Date:  1986-07-18       Impact factor: 41.582

2.  Coordinate regulation of type IX and type II collagen synthesis during growth of chick chondrocytes in retinoic acid or 5-bromo-2'-deoxyuridine.

Authors:  N Yasui; P D Benya; M E Nimni
Journal:  J Biol Chem       Date:  1986-06-15       Impact factor: 5.157

3.  Biochemical properties and immunolocalization of minor collagens in foetal calf cartilage.

Authors:  S Ricard-Blum; D J Hartmann; D Herbage; C Payen-Meyran; G Ville
Journal:  FEBS Lett       Date:  1982-09-20       Impact factor: 4.124

4.  Retinoic acid rapidly reduces cartilage matrix synthesis by altering gene transcription in chondrocytes.

Authors:  W E Horton; Y Yamada; J R Hassell
Journal:  Dev Biol       Date:  1987-10       Impact factor: 3.582

5.  Type X collagen synthesis during endochondral ossification in fracture repair.

Authors:  W T Grant; G J Wang; G Balian
Journal:  J Biol Chem       Date:  1987-07-15       Impact factor: 5.157

6.  Effect of retinoids on collagen production by chondrocytes in culture.

Authors:  R Hein; T Krieg; P K Mueller; O Braun-Falco
Journal:  Biochem Pharmacol       Date:  1984-10-15       Impact factor: 5.858

7.  Identity of the immunoglobulin heavy-chain-binding protein with the 78,000-dalton glucose-regulated protein and the role of posttranslational modifications in its binding function.

Authors:  L M Hendershot; J Ting; A S Lee
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

8.  Modulation of the rabbit chondrocyte phenotype by retinoic acid terminates type II collagen synthesis without inducing type I collagen: the modulated phenotype differs from that produced by subculture.

Authors:  P D Benya; S R Padilla
Journal:  Dev Biol       Date:  1986-11       Impact factor: 3.582

9.  Independence of cell shape and loss of cartilage matrix production during retinoic acid treatment of cultured chondrocytes.

Authors:  W Horton; J R Hassell
Journal:  Dev Biol       Date:  1986-06       Impact factor: 3.582

10.  Alterations in chondrocyte cytoskeletal architecture during phenotypic modulation by retinoic acid and dihydrocytochalasin B-induced reexpression.

Authors:  P D Brown; P D Benya
Journal:  J Cell Biol       Date:  1988-01       Impact factor: 10.539

View more
  6 in total

Review 1.  Drug-induced rheumatic disorders: incidence, prevention and management.

Authors:  P Vergne; P Bertin; C Bonnet; C Scotto; R Trèves
Journal:  Drug Saf       Date:  2000-10       Impact factor: 5.606

2.  Change in the synthesis rates of ocular retinoic acid and scleral glycosaminoglycan during experimentally altered eye growth in marmosets.

Authors:  David Troilo; Debora L Nickla; James R Mertz; Jody A Summers Rada
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-05       Impact factor: 4.799

3.  Differential liver protein expression during schistosomiasis.

Authors:  Marina Harvie; Thomas William Jordan; Anne Camille La Flamme
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

4.  Identification of phosphoproteins as possible differentiation markers in all-trans-retinoic acid-treated neuroblastoma cells.

Authors:  Giorgia Mandili; Cristina Marini; Franco Carta; Cristina Zanini; Mauro Prato; Amina Khadjavi; Franco Turrini; Giuliana Giribaldi
Journal:  PLoS One       Date:  2011-05-05       Impact factor: 3.240

Review 5.  SHetA2 Attack on Mortalin and Colleagues in Cancer Therapy and Prevention.

Authors:  Doris Mangiaracina Benbrook
Journal:  Front Cell Dev Biol       Date:  2022-02-23

Review 6.  Ribosome and Translational Control in Stem Cells.

Authors:  Mathieu Gabut; Fleur Bourdelais; Sébastien Durand
Journal:  Cells       Date:  2020-02-21       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.